Portfolio Lab

Healthequity, Inc.

  • Stock
  • Ticker HQY
  • ISIN US42226A1079
  • Nasdaq

Industrials · Business services · USA

$94.75 −2.70%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Healthequity, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

HQYGlobal equities (VT)

$10,000 grew to $22,936. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −60.7% in 12/2021, measured from the peak in 11/2018. It took 72 months to get back to the old peak.

1-year return
−5.9%
5-year return p.a.
+9.1%
10-year return p.a.
+8.7%
Volatility p.a.
40.9%
Largest decline
−60.7%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end10/202401/202504/202507/202510/202501/202604/202607/2026
Income statement
Revenue300312331326322335355351
Gross profit197189224233228228256258
Operating income20428390797110399
EBITDA2181122907911014199
Net income5.726546052506966
Earnings per share0.060.300.610.680.590.580.820.78
Balance sheet
Total assets3,4883,4493,4163,4173,3983,3803,3063,271
Liabilities1,3641,3341,2921,2701,2641,2731,2591,281
Equity2,1252,1152,1242,1462,1342,1072,0471,990
Cash322296288304309319265256
Long-term debt1,0811,0561,0571,007982957943931
Cash flow
Operating cash flow91766513613911898136
Capital expenditure-0.3-0.3-0.1-0.8-0.8-0.3-0.4-1.0
Free cash flow90756513513811897135

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2024 at +44.7%, weakest 2021 at −36.5%. 6 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
27 Aug 2026$0.78
28 May 2026$0.82
17 Mar 2026$0.58
3 Dec 2025$0.59
2 Sep 2025$0.68
3 Jun 2025$0.61
18 Mar 2025$0.30
9 Dec 2024$0.06
3 Sep 2024$0.40
3 Jun 2024$0.33
22 Mar 2024$0.30
5 Dec 2023$0.17

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€7.1bn
Market cap in trading currency
$7.84bn
Enterprise value
$8.51bn
P/E
34.2
P/S
5.75
P/B
3.94
EV/Sales
6.25
EV/EBITDA
19.8
Earnings yield
2.9%
FCF yield
6.2%

Results (last four quarters)

Revenue
$1.36bn
Gross profit
$970m
EBITDA
$429m
Net income
$236m
Earnings per share
$2.77
Revenue per share
$16.47
Revenue growth
+7.6%
Earnings growth
+9.7%

Profitability

Gross margin
71.2%
Operating margin
25.8%
Net margin
17.4%
Return on equity
11.4%
Return on assets
7.2%

Balance sheet and cash flow

Cash
$256m
Cash per share
$3.09
Financial debt
$931m
Debt/equity %
47
Current ratio
2.99
Book value per share
$24.06
Operating cash flow
$490m
Free cash flow
$488m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
82.7m
Volume
741,341
Avg. volume 3 months
873,677
Relative volume
0.8

Price and technicals

Price
$94.75
1 day
−2.7%
52-week high
$108.84
52-week low
$73.21
Distance to 52-week high
−12.9%
Distance to 52-week low
+29.4%
Distance to 50-day line
−1.9%
Distance to 200-day line
+4.9%
RSI (14)
39
Volatility 1M
40.2%

Performance

1 week
−8.4%
1 month
−6.2%
3 months
−10.1%
6 months
+7.5%
YTD
+3.4%
1 year
−8.5%

Dates

Fiscal year end
31 Jan 2026
Most recent quarter
31 Jul 2026

Frequently asked questions

How has HQY performed since 11/2016?

$10,000 grew to $22,936 by 20 Nov 2026, which is +8.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is HQY?

Volatility was 40.9% per year, measured on monthly returns. The largest decline from a peak was −60.7%, with the low in 12/2021.

How does HQY compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, HQY returned +8.7% at 40.9%. The correlation of monthly returns was 0.25; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Healthequity, Inc. (HQY): Return and risk | Portfolio Lab